2025 annual financial data
Heron Therapeutics 2025 Operating margin
Direct answer
Operating margin was -1.64%.
Operating income was -2,538,000 USD and net income was -20,195,000 USD.
Operating cash flow was -27,591,000 USD.
Get free Heron Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 154,904,000 USD
- Operating income
- -2,538,000 USD
- Net income
- -20,195,000 USD
- Operating cash flow
- -27,591,000 USD